Pain Therapeutics Inc (NASDAQ:PTIE)

Data as of Aug 22
 -0.05 / -1.20%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Pain Therapeutics, Inc. is a biopharmaceutical company, which develops novel drugs. It also engages in the developing pipeline of novel drug candidates in the area of oncology and hematology. The company developing a novel drug candidate to treat metastatic melanoma, a deadly form of skin cancer. It has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. The company was founded by Remi Barbier and in May 1998 and is headquartered in Austin, TX.

Contact Information

Pain Therapeutics, Inc.
7801 North Capital of Texas Highway
Austin Texas 78731
P:(512) 501-2444
Investor Relations:
(512) 501-2450



Other institutional49.25%
Individual stakeholders32.13%
Mutual fund holders12.21%

Top Executives

Remi BarbierChairman, President & Chief Executive Officer
Nadav FriedmannDirector, Chief Operating & Medical Officer
Peter S. RoddyChief Financial Officer & VP-Investor Relations
Grant L. SchoenhardChief Scientific Officer
George ThorntonSenior Vice President-Technology

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.